Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Ophthalmology

Decoding the Tests: Mapping Your Eye Health

At a Glance

CRVO diagnostic tests, such as OCT and fluorescein angiography, map retinal damage to determine if your condition is ischemic (severe lack of oxygen) or non-ischemic. These eye scans help doctors measure swelling (macular edema) and guide your treatment plan.

Navigating a CRVO diagnosis often involves a deep dive into advanced imaging and specialized medical terms. Understanding these tools and classifications is essential because they determine your treatment path and help your care team monitor how your eye is healing [1][2].

The Two Types: Ischemic vs. Non-Ischemic

The most important distinction your doctor will make is whether your condition is ischemic or non-ischemic. This tells them how much “breathable” oxygen is reaching your retina [3][4].

  • Non-Ischemic CRVO (Milder): This is the most common form. While blood flow is restricted, the retina is still receiving enough oxygen to function, though it may be struggling with swelling (macular edema) [3].
  • Ischemic CRVO (Severe): This occurs when blood flow is so restricted that parts of the retina are starved of oxygen (a state called ischemia) [3][4]. Ischemic eyes are at a higher risk for growing abnormal new blood vessels and often require more intensive monitoring [4][5].

Key Diagnostic Tests

Your doctor uses specialized cameras to look inside your eye and map out the damage. You will likely encounter these three tests:

1. Optical Coherence Tomography (OCT)

Think of an OCT as a “high-definition ultrasound” for your eye, but using light instead of sound. It provides a cross-section view of the layers of your retina [6][7].

  • What it shows: It measures macular edema (swelling) and central retinal thickness (CRT) [6]. Doctors use these images to decide if you need an injection and to see if previous treatments are working [8][9].

2. Fluorescein Angiography (FA)

This test involves injecting a safe yellow dye into your arm. As the dye travels to your eye, a camera takes photos to track the blood flow [1][8].

  • What it shows: It highlights areas of capillary non-perfusion—places where blood is no longer flowing [1]. If a significant area of the retina shows this “dropout” (often measured as greater than 10 “disc areas” by standard guidelines, or a high percentage like 35% on ultra-widefield imaging), the case is classified as ischemic [1][10].

3. OCT Angiography (OCTA)

This is a newer, non-invasive version of the FA that doesn’t require dye. It uses light to create a 3D map of the blood vessels [2][11].

  • What it shows: It is particularly good at looking at the Foveal Avascular Zone (FAZ), which is the very center of your vision [2][11]. If the FAZ looks enlarged or “broken,” it indicates damage to the fine vessels you need for reading and detail work [11][12].

Decoding Your Clinical Notes

You may see these terms in your records or hear your doctor mention them during an exam:

  • Macular Edema: Swelling in the center of the retina. This is the #1 cause of blurred vision in CRVO [13][14].
  • Relative Afferent Pupillary Defect (RAPD): During a “swinging flashlight test,” your doctor compares how your two pupils react to light. If the pupil in the affected eye doesn’t constrict as strongly as the healthy eye when the light moves, it is called an RAPD [15][16]. This is a clinical sign that the affected retina is severely starved of oxygen (ischemic) [10][17].
  • Capillary Non-Perfusion: An area of the retina where the smallest blood vessels have closed off and are no longer delivering oxygen [1][8].
  • Foveal Avascular Zone (FAZ): The tiny area in the dead-center of your macula that normally has no blood vessels [11][12]. Damage here often predicts how well your detail-vision might recover [11].
Term Simple Definition Why it Matters
Ischemia Lack of oxygen Increases risk of severe complications [4]
Edema Swelling/Fluid The main cause of blurriness; treated with injections [13]
RAPD Weak pupil reflex Sign of significant retinal damage compared to the good eye [17]
Non-perfusion “Dead zones” in vessels Determines if you have the Ischemic type [1]

Common questions in this guide

What is the difference between ischemic and non-ischemic CRVO?
Non-ischemic CRVO is the milder and more common form where the retina still receives enough oxygen despite restricted blood flow. Ischemic CRVO is severe, occurring when blood flow is so blocked that parts of the retina are starved of oxygen, increasing the risk of severe complications.
What does an OCT scan show for central retinal vein occlusion?
An Optical Coherence Tomography (OCT) scan acts like a high-definition ultrasound for your eye, using light to show cross-sections of the retina. Doctors use it to measure retinal swelling, known as macular edema, and to see if previous treatments like eye injections are working.
What is macular edema and why does it affect my vision?
Macular edema is swelling in the center of the retina caused by fluid buildup. It is the primary cause of blurred vision in CRVO patients and is typically treated with eye injections.
How does a fluorescein angiography (FA) test work?
A fluorescein angiography involves injecting a safe yellow dye into your arm to track blood flow as it reaches your eye. The camera highlights areas where blood is no longer flowing, which helps your doctor determine if your condition is ischemic.
What does it mean if my doctor finds a Relative Afferent Pupillary Defect (RAPD)?
An RAPD is detected during a flashlight test when the pupil in your affected eye does not constrict as strongly to light as your healthy eye. This clinical sign indicates that your affected retina is severely starved of oxygen.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my imaging, what percentage or 'disc areas' of my retina show lack of blood flow?
  2. 2.How has the size of my Foveal Avascular Zone (FAZ) changed since my last visit?
  3. 3.Did my pupil exam show a Relative Afferent Pupillary Defect (RAPD), and what does that mean for my prognosis?
  4. 4.Looking at my OCT scan, is the fluid in my macula resolving?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    USE OF THE ISCHEMIC INDEX ON WIDEFIELD FLUORESCEIN ANGIOGRAPHY TO CHARACTERIZE A CENTRAL RETINAL VEIN OCCLUSION AS ISCHEMIC OR NONISCHEMIC.

    Thomas AS, Thomas MK, Finn AP, Fekrat S

    Retina (Philadelphia, Pa.) 2019; (39(6)):1033-1038 doi:10.1097/IAE.0000000000002126.

    PMID: 29474305
  2. 2

    The role of optical coherence tomography angiography in distinguishing ischemic versus non-ischemic central retinal vein occlusion.

    An W, Zhao Q, Yu R, Han J

    BMC ophthalmology 2022; (22(1)):413 doi:10.1186/s12886-022-02637-y.

    PMID: 36307778
  3. 3

    IMPACT OF RETINAL ISCHEMIA ON FUNCTIONAL AND ANATOMICAL OUTCOMES AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN PATIENTS WITH RETINAL VEIN OCCLUSION.

    Khayat M, Wright DM, Yeong J, et al.

    Retina (Philadelphia, Pa.) 2020; (40(6)):1098-1109 doi:10.1097/IAE.0000000000002571.

    PMID: 31157714
  4. 4

    ISCHEMIC CENTRAL RETINAL VEIN OCCLUSION IN THE ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ERA.

    Tam EK, Golchet P, Yung M, et al.

    Retina (Philadelphia, Pa.) 2018; (38(2)):292-298 doi:10.1097/IAE.0000000000001546.

    PMID: 28207609
  5. 5

    Central retinal thickness changes and risk of neovascular glaucoma after intravitreal bevacizumab injection in patients with central retinal vein occlusion.

    Lee YH, Kim YC

    Scientific reports 2022; (12(1)):2051 doi:10.1038/s41598-022-06121-x.

    PMID: 35136171
  6. 6

    The impact of structural optical coherence tomography changes on visual function in retinal vein occlusion.

    Michl M, Liu X, Kaider A, et al.

    Acta ophthalmologica 2021; (99(4)):418-426 doi:10.1111/aos.14621.

    PMID: 32996711
  7. 7

    Analysis of Morphologic and Functional Outcomes in Macular Edema due to Central Retinal Vein Occlusion Treated with Intravitreal Dexamethasone Implant.

    Niro A, Sborgia G, Sborgia A, et al.

    Journal of ophthalmology 2018; (2018()):5604632 doi:10.1155/2018/5604632.

    PMID: 30271628
  8. 8

    Hyperreflectivity of Inner Retinal Layers as a Quantitative Parameter of Ischemic Damage in Acute Retinal Vein Occlusion (RVO): An Optical Coherence Tomography Study.

    Furashova O, Matthè E

    Clinical ophthalmology (Auckland, N.Z.) 2020; (14()):2453-2462 doi:10.2147/OPTH.S260000.

    PMID: 32921978
  9. 9

    BETTER PROGNOSIS FOR EYES WITH PRESERVED FOVEAL DEPRESSION AFTER INTRAVITREAL RANIBIZUMAB INJECTION FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION.

    Kitagawa S, Yasuda S, Ito Y, et al.

    Retina (Philadelphia, Pa.) 2018; (38(7)):1354-1360 doi:10.1097/IAE.0000000000001707.

    PMID: 28538263
  10. 10

    Evaluation of optical coherence tomography angiography role in differentiating ischemic and non-ischemic central retinal vein occlusion.

    Elhabiby IAM, Mandour SS, Nage SAM

    International ophthalmology 2025; (45(1)):374 doi:10.1007/s10792-025-03731-y.

    PMID: 40911087
  11. 11

    Retinal Capillary Network and Foveal Avascular Zone in Eyes with Vein Occlusion and Fellow Eyes Analyzed With Optical Coherence Tomography Angiography.

    Adhi M, Filho MA, Louzada RN, et al.

    Investigative ophthalmology & visual science 2016; (57(9)):OCT486-94 doi:10.1167/iovs.15-18907.

    PMID: 27442342
  12. 12

    Optical Coherence Tomography Angiography of the Foveal Avascular Zone in Retinal Vein Occlusion.

    Wons J, Pfau M, Wirth MA, et al.

    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 2016; (235(4)):195-202 doi:10.1159/000445482.

    PMID: 27160007
  13. 13

    Location of a Dexamethasone Implant at the Macula after Intravitreal Injection in a Silicone Oil-Filled Eye.

    Esenulku CM, Gunay M

    Case reports in ophthalmological medicine 2016; (2016()):5107652 doi:10.1155/2016/5107652.

    PMID: 27999699
  14. 14

    Central Retinal Vein Occlusion in a 46-Year-Old Man with COVID-19: Case Report and Review of the Literature.

    Miller CG, Kim BJ

    Case reports in ophthalmology 2021; (12(2)):646-652 doi:10.1159/000517417.

    PMID: 34413756
  15. 15

    Predictive values of initial semi-quantitative assessment of relative afferent pupillary defect for neovascularization in central retinal vein occlusion.

    Ducloyer JB, Bensaber S, Khanna RK, et al.

    Acta ophthalmologica 2021; (99(2)):215-220 doi:10.1111/aos.14544.

    PMID: 32701208
  16. 16

    Optic disc edema and visual loss from paracentral acute middle maculopathy mimicking optic neuritis.

    Pereira CR, Benassi TSA, Mello LGM, et al.

    Arquivos brasileiros de oftalmologia 2024; (88(2)):e20230185 doi:10.5935/0004-2749.2023-0185.

    PMID: 39319908
  17. 17

    Posterior Vitreous Detachment and Risk of Neovascular Glaucoma in Eyes with Prior Retinal Vascular Occlusions.

    Palmer LD, Peterson JD, Evans JK, et al.

    Ophthalmology and therapy 2024; (13(11)):3013-3024 doi:10.1007/s40123-024-01039-1.

    PMID: 39342534

This page explains CRVO diagnostic tests and clinical terminology for educational purposes only. Always consult your ophthalmologist or retina specialist to interpret your specific eye scans and clinical exam results.

Get notified when new evidence is published on Central retinal vein occlusion.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.